• Rapamycin (Sirolimus) for mTOR Pathway Studies

  2026-09-29

  Rapamycin (Sirolimus) provides a potent, mechanism-oriented way to interrogate mTOR signaling in cancer, immunology, extracellular-vesicle, and mitochondrial disease experiments. This workflow-focused guide shows how to connect nanomolar pathway inhibition with functional assays, including B-cell ectosome release, lens epithelial apoptosis, and Leigh syndrome models.

• NSC-23766: A Rac GTPase Inhibitor in Cell Models

  2026-09-29

  NSC-23766 is a practical Rac GTPase inhibitor for connecting Rac1 activation with apoptosis, endothelial barrier behavior, and glucose-uptake signaling. This workflow-focused guide explains concentration selection, controls, assay sequencing, and troubleshooting for cancer, vascular, and metabolic cell models.

• Sulfo-NHS-LC-Biotin Protocol Guide

  2026-09-28

  Sulfo-NHS-LC-Biotin provides water-compatible, irreversible biotin labeling of accessible primary amines on proteins, peptides, and intact-cell surfaces. It is suited to streptavidin capture and biotin-avidin detection workflows, but not to intracellular labeling of intact cells or reversible modification strategies.

• Bafilomycin C1 in Phenotypic Assay Interpretation

  2026-09-28

  Bafilomycin C1 is a vacuolar H+-ATPases inhibitor that can help researchers test whether lysosomal acidification contributes to phenotypes in high-content cell assays. This article connects that mechanistic use to deep-learning cardiotoxicity screening while clarifying what the evidence supports—and what it does not.

• KX2-391 Dihydrochloride: Research Workflows

  2026-09-27

  KX2-391 dihydrochloride supports distinct experimental questions—from Src/tubulin biology in cancer models to HBV transcription and BoNT/A assays—provided each pathway is measured with orthogonal readouts. This guide translates reported activity ranges into practical assay designs, controls, and troubleshooting decisions without treating evidence from one field as validation in another.

• TMRE (C8197) for Mitochondrial Membrane Potential

  2026-09-26

  Tetramethylrhodamine ethyl ester perchlorate (TMRE) is a rhodamine-like fluorescent dye used to report mitochondrial membrane potential in live cells. Its potential-sensitive accumulation supports mitochondrial imaging and functional assays, but it does not directly measure ROS or identify the cause of mitochondrial injury.

• Phosbind Acrylamide for Pathway Analysis

  2026-09-25

  Phosbind Acrylamide adds a phosphate-sensitive separation step to SDS-PAGE, helping researchers compare protein phosphorylation states without relying on phospho-specific antibodies. Use it to complement studies of signaling and apoptosis—while keeping mobility shifts distinct from direct evidence of a pathway mechanism.

• Dibutyryl-cAMP in Sex-Aware Neural Differentiation

  2026-09-25

  Explore how Dibutyryl-cAMP, sodium salt can serve as a controlled perturbation in sex-aware neural differentiation research. A 2024 human stem-cell study shows why cell-line sex and developmental stage should shape cAMP experiments and their interpretation.

• Physiological vs Pathological Aβ in Human Synapses

  2026-09-24

  Using live human brain slice cultures, this study distinguishes the synaptic effects of experimentally altered physiological amyloid-β from those of Alzheimer’s disease brain extract. Its findings suggest that both increasing and decreasing physiological Aβ can disrupt presynaptic markers, while pathological extract produces a different pattern involving postsynaptic Aβ uptake.

• Fingolimod (FTY720) in T-Cell Engineering Studies

  2026-09-24

  Fingolimod (FTY720) offers researchers a way to probe S1P-dependent immune-cell trafficking alongside emerging, magnetically guided T-cell strategies. This workflow-focused guide explains how to test its effects without assuming it will improve tumor infiltration—and how to spot confounding toxicity early.

• Axitinib Assays: Separating Arrest from Cell Death

  2026-09-23

  Axitinib (AG 013736) is a potent VEGFR inhibitor, but a single viability endpoint can blur its vascular effects with growth arrest or cell killing. This guide connects its pharmacology to a practical, two-metric strategy for designing and interpreting cancer research assays.

• H2S Deficiency, ER Stress, and Diabetic Cardiomyopathy

  2026-09-23

  The reference study links reduced endogenous hydrogen sulfide production with palmitate-associated lipotoxicity and endoplasmic reticulum stress in diabetic cardiomyopathy. By combining patient samples, a streptozotocin-induced rat model, and AC16 cardiomyocytes, it shows that H2S supplementation and ER-stress inhibition can reduce lipid accumulation and myocardial injury, while also defining useful parameters for mechanistic follow-up studies.

• Annexin V-PE Reagent for Apoptosis Detection

  2026-09-22

  Annexin V-PE Reagent detects cell-surface phosphatidylserine, an early apoptosis-associated signal, by fluorescence microscopy or flow cytometry. The K2280 reagent supports a one-step staining workflow completed in 15–30 minutes when used with the specified binding-buffer system.

• Candida krusei Forms Trigger Distinct BMEC Apoptosis

  2026-09-22

  Miao and colleagues show that the yeast and hypha phases of Candida krusei both induce apoptosis in bovine mammary epithelial cells, but through different dominant pathways. The yeast phase primarily engages mitochondrial apoptosis, whereas the hypha phase is associated with death ligand/receptor signaling, with TLR2/ERK and JNK/ERK pathways contributing to the response.

• FITC Goat Anti-Rabbit IgG (H+L) Antibody Guide

  2026-09-21

  Build reproducible immunofluorescence, flow cytometry, and tissue-imaging workflows around a fluorescein-conjugated secondary antibody that amplifies rabbit primary-antibody signals. This guide connects practical assay design with the receptor-biased IL-11 research landscape while emphasizing controls, storage, and troubleshooting.

681 records 1/46 page Next 12345 下5页 Last page